ANIX
Price
$2.70
Change
-$0.06 (-2.17%)
Updated
Apr 3, 02:28 PM (EDT)
Capitalization
88.86M
64 days until earnings call
SGMO
Price
$0.63
Change
-$0.02 (-3.08%)
Updated
Apr 3, 02:59 PM (EDT)
Capitalization
146.78M
27 days until earnings call
Ad is loading...

ANIX vs SGMO

Header iconANIX vs SGMO Comparison
Open Charts ANIX vs SGMOBanner chart's image
Anixa Biosciences
Price$2.70
Change-$0.06 (-2.17%)
Volume$100
Capitalization88.86M
Sangamo Therapeutics
Price$0.63
Change-$0.02 (-3.08%)
Volume$23.06K
Capitalization146.78M
ANIX vs SGMO Comparison Chart
Loading...
ANIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SGMO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANIX vs. SGMO commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANIX is a Hold and SGMO is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (ANIX: $2.76 vs. SGMO: $0.65)
Brand notoriety: ANIX and SGMO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANIX: 45% vs. SGMO: 341%
Market capitalization -- ANIX: $88.86M vs. SGMO: $146.78M
ANIX [@Biotechnology] is valued at $88.86M. SGMO’s [@Biotechnology] market capitalization is $146.78M. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANIX’s FA Score shows that 0 FA rating(s) are green whileSGMO’s FA Score has 0 green FA rating(s).

  • ANIX’s FA Score: 0 green, 5 red.
  • SGMO’s FA Score: 0 green, 5 red.
According to our system of comparison, both ANIX and SGMO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANIX’s TA Score shows that 3 TA indicator(s) are bullish while SGMO’s TA Score has 4 bullish TA indicator(s).

  • ANIX’s TA Score: 3 bullish, 5 bearish.
  • SGMO’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, SGMO is a better buy in the short-term than ANIX.

Price Growth

ANIX (@Biotechnology) experienced а -12.38% price change this week, while SGMO (@Biotechnology) price change was -22.70% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -7.69%. For the same industry, the average monthly price growth was -9.74%, and the average quarterly price growth was -14.08%.

Reported Earning Dates

ANIX is expected to report earnings on Jun 06, 2025.

SGMO is expected to report earnings on Apr 30, 2025.

Industries' Descriptions

@Biotechnology (-7.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SGMO($147M) has a higher market cap than ANIX($88.9M). ANIX YTD gains are higher at: 18.966 vs. SGMO (-35.961). ANIX has higher annual earnings (EBITDA): -13.58M vs. SGMO (-123.99M). SGMO has more cash in the bank: 39.2M vs. ANIX (17.3M). ANIX has less debt than SGMO: ANIX (230K) vs SGMO (27.7M). SGMO has higher revenues than ANIX: SGMO (52.3M) vs ANIX (0).
ANIXSGMOANIX / SGMO
Capitalization88.9M147M60%
EBITDA-13.58M-123.99M11%
Gain YTD18.966-35.961-53%
P/E RatioN/AN/A-
Revenue052.3M-
Total Cash17.3M39.2M44%
Total Debt230K27.7M1%
FUNDAMENTALS RATINGS
ANIX vs SGMO: Fundamental Ratings
ANIX
SGMO
OUTLOOK RATING
1..100
1820
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
61
Fair valued
PROFIT vs RISK RATING
1..100
88100
SMR RATING
1..100
9899
PRICE GROWTH RATING
1..100
6092
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SGMO's Valuation (61) in the Biotechnology industry is in the same range as ANIX (75) in the Computer Peripherals industry. This means that SGMO’s stock grew similarly to ANIX’s over the last 12 months.

ANIX's Profit vs Risk Rating (88) in the Computer Peripherals industry is in the same range as SGMO (100) in the Biotechnology industry. This means that ANIX’s stock grew similarly to SGMO’s over the last 12 months.

ANIX's SMR Rating (98) in the Computer Peripherals industry is in the same range as SGMO (99) in the Biotechnology industry. This means that ANIX’s stock grew similarly to SGMO’s over the last 12 months.

ANIX's Price Growth Rating (60) in the Computer Peripherals industry is in the same range as SGMO (92) in the Biotechnology industry. This means that ANIX’s stock grew similarly to SGMO’s over the last 12 months.

ANIX's P/E Growth Rating (100) in the Computer Peripherals industry is in the same range as SGMO (100) in the Biotechnology industry. This means that ANIX’s stock grew similarly to SGMO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ANIXSGMO
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 11 days ago
84%
Bullish Trend 8 days ago
77%
Declines
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
ANIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SGMO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FEYTX25.70N/A
N/A
Fidelity Advisor Asset Manager 85% M
ELCRX35.51N/A
N/A
Eaton Vance Growth R
GINUX24.52N/A
N/A
Goldman Sachs Small Cap Gr Insghts R6
VLNPX37.98N/A
N/A
Voya Small Cap Growth R6
UEPSX17.74N/A
N/A
ProFunds Europe 30 Svc

ANIX and

Correlation & Price change

A.I.dvisor tells us that ANIX and RYTM have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ANIX and RYTM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANIX
1D Price
Change %
ANIX100%
+1.10%
RYTM - ANIX
33%
Poorly correlated
+3.92%
PRTA - ANIX
31%
Poorly correlated
+3.41%
SGMO - ANIX
29%
Poorly correlated
+14.58%
DNLI - ANIX
29%
Poorly correlated
+11.80%
CDTX - ANIX
27%
Poorly correlated
-2.91%
More

SGMO and

Correlation & Price change

A.I.dvisor indicates that over the last year, SGMO has been loosely correlated with AXON. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if SGMO jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SGMO
1D Price
Change %
SGMO100%
+14.58%
AXON - SGMO
51%
Loosely correlated
+3.18%
ARRY - SGMO
48%
Loosely correlated
+1.65%
BCRX - SGMO
46%
Loosely correlated
+2.48%
RPRX - SGMO
45%
Loosely correlated
+0.35%
AGEN - SGMO
43%
Loosely correlated
+1.87%
More